Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease

American Journal of Medicine

Volumn 102, Issue 2, 1997, Pages 200-207

  Peek Jr , Richard M ^a,b   Blaser, Martin J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; DUODENUM ULCER; GASTRITIS; HELICOBACTER PYLORI; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ACID SECRETION; ULCEROGENESIS;

EID: 0342547309     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00273-2     Document Type: Article

References (93)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.
2. Dooley CP, Fitzgibbons PL, Cohen H, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. NEJM. 1989;321:1562-1566.
3. Peterson WL. Helicobacter pylori and peptic ulcer disease. NEJM. 1991;324:1043-1048.
4. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infections. Epidemiol Rev. 1991;13:42-59.
5. Rauws EA, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988;94:33-39.
6. Carrick J, Lee A, Hazell S, et al. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut. 1989;30. 790-797.
7. Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers=ma 12-month follow-up study. Lancet. 1987;2:1109-1111.
8. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;2:1437-1442.
9. Nomura A, Stemmermann GN, Chyou P, et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med. 1994;120:977-981.
10. Cullen DJE, Collins BJ, Christiansen KJ, et al. Long term risk of peptic ulcer disease in people with Helicobacter pylori infection=ma community based study. Gut. 1993;34(suppl 1):72. Abstract.
11. Sipponen P, Varis K, Fraki O, et al. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical followup study of 454 outpatients. Scand J Gastroenterol. 1990;25:966-973.
12. Hentschel E, Brandstatter G, Dragoisics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. NEJM. 1993;328:308-312.
13. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990;335:1233-1235.
14. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med. 1992;116:705-708.
15. Hosking SW, Ling TK, Chung SC, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994;343:508-510.
16. Blaser MJ. Helicobacter pylori: its role in disease. Clin Infect Dis. 1992;15:386-391.
17. Nomura A, Stemmermann GN, Chyou P, et al. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. NEJM. 1991;325:1132-1136.
18. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. NEJM. 1994;330:1267-1271.
19. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735-6740.
20. Morris A, Nicholson G. Experimental and accidental C pylori infection of humans. In: Blaser MJ, ed. Campylobacter pylori in Gastritis and Peptic Ulcer Disease. New York: Igaku-Shoin; 1989:61-72.
21. El-Omar E, Penman I, Ardill JES, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995;109:681-691.
22. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology. 1996;110:926-938.
23. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun. 1991;59:2470-2475.
24. Marshall BJ, Barrett LJ, Prakash C, et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 1990;99:697-702.
25. Evans DJJ, Evans DG, Kirkpatrick SS, Graham DY. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathog. 1991;10:15-26.
26. Eaton KA, Morgan DR, Krakowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun. 1989;57:1119-1125.
27. Caselli M, Alvisi V. Bacterial adhesion and Helicobacter pylori. Gut. 1991;32:111-112.
28. Hessey SJ, Spencer J, Wyatt JI, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990:31:134-138.
29. Wyatt JI, Rathbone BJ, Sobala GM, et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol. 1990;43:981-986.
30. Evans DG, Evans DJJ, Moulds JJ, Graham DY. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun. 1988:56:2896-2906.
31. Emody L, Carlsson A, Ljungh A, Wadstrom T. Mannose-resistant haemagglutination by Campylobacter pylori. Scand J Infect Dis. 1988;20:353-354.
32. Lingwood CA, Wasfy G, Han H, Huesca M. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect Immun. 1993;61:2474-2478.
33. Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262: 1892-1895.
34. Pérez-Pérez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988;109:11-17.
35. Crabtree JE, Shallcross TM, Wyatt JI, et al. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sci. 1991;36:1266-1273.
36. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990;58:603-610.
37. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991;338:332-335.
38. Evans DJJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology. 1989;96:1004-1008.
39. Tosi MF, Czinn SJ. Opsonic activity of specific human IgG against Helicobacter pylori. J Infect Dis. 1990;162:156-162.
40. Gonzalez-Valencia G, Pérez-Pérez GI, Washburn RG, Blaser MJ. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter. 1996;1:28-33.
41. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastric and peptic ulceration. J Clin Pathol. 1986;39:353-365.
42. Mai UE, Pérez-Pérez GI, Allen JB, et al. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med. 1992;175:517-525.
43. Denizot Y, Sobhani I, Rambaud JC, et al. Paf-acether synthesis by Helicobacter pylori. Gut. 1990;31:1242-1245.
44. Tufano MA, Rossano F, Catalanotti P, et al. Immunobiological activities of Helicobacter pylori porins. Infect Immun. 1994;62:1392-1399.
45. Yoshida N, Granger DN, Evans DJ, et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology. 1993;105:1431-1440.
46. Engstrand L, Scheynius A, Pahlson C, et al. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun. 1989;57:827-832.
47. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991;32:1473-1477.
48. Fan XJ, Chua A, O'Connell MA, et al. Interferon-gamma and tumor necrosis factor production in patients with Helicobacter pylori infection. Irish J Med Sci. 1993;162:408-411.
49. Crabtree JE, Peichl P, Wyatt JI, et al. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol. 1993;37:65-70.
50. + Helicobacter pylori strains. Lab Invest. 1995;71:760-770.
51. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol. 1991;6:125-130.
52. Oppenheim JJ, Zachariae COC, Mukaiada N, Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Ann Rev Immunol. 1991;9:617-648.
53. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
54. Sharma SA, Tummuru MKR, Miller GG, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995;63:1681-1687.
55. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988;26:93-99.
56. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989;27:225-226.
57. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992;267:10570-10575.
58. Rautelin H, Blomberg B, Jarnerot G, Danielsson D. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol. 1994;29:128-132.
59. Goossens H, Glupczynski Y, Burette A, et al. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett. 1992;1:153-159.
60. Tee W, Lambert JR, Pegorer M, Dwyer B. Cytotoxin production by Helicobacter pylori more common in peptic ulcer disease. Gastroenterology. 1993;104:A789
61. Cover TL, Tummuru MKR, Cao P, et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem. 1994;269:10566-10573.
62. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270:17771-17777.
63. Peek RM, Atherton JC, Cover TL, et al. Association between gastric mucosal IL-8 levels and vacA genotypes of infecting Helicobacter pylori strains. Gastroenterology. 1995;108(suppl):A891.
64. Telford JL, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994;179:1653-1658.
65. Ghiari P, Marchetti M, Blaser MJ, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun. 1995;63:4154-4160.
66. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799-1809.
67. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993;90:5791-5795.
68. Cover TL, Glupczynski Y, Lage AP, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995;33:1496-1500.
69. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128-kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 1993;12:739-745.
70. Crabtree JE, Farmery SM, Lindley IJD, et al. CagA cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol. 1994;47:945-950.
71. Akopyants NS, Kersulyte D, Berg DE. Cagll, a new multigene locus associated with virulence in Helicobacter pylori. Gut. 1995;37:Supplement 1.A1
72. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homolog of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol. 1995;18:867-876.
73. Johnston BJ, Reed PI, Ali MH. Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut. 1986;27: 1132-1137.
74. Wyatt JI, Rathbone BJ, Dixon MF. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol. 1987;40:841-848.
75. El-Omar E, Penman I, Dorrian CA, et al. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 1993;34:1060-1065.
76. Graham DY, Opekun A, Lew GM, et al. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterology. 1990;85:394-398.
77. Karnes WE, Ohning GV, Sytnik B, et al. Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH. Rev Infect Dis. 1991;13 Suppl 8:S665-S670.
78. Smith JT, Pounder RE, Nwokolo CU, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut. 1990;31:522-525.
79. McColl KE. Helicobacter pylori colonization and alterations in gastric physiology. In: Rathbone BJ, Heatley RV, eds. Helicobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific; 1992;198-208.
80. Dixon MF. Helicobacter pylori and chronic gastritis. In: Rathbone BJ, Heatley RV, eds. Helicobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific; 1992;124-139.
81. Sipponen P, Seppala K. Gastric carcinoma: failed adaptation to Helicobacter pylori. Scand J Gastroenterology. 1992;27(suppl 193):33-38.
82. Calam J. Acid secretion. In: Northfield TC, Mendall M, Goggin PM, eds. Helicobacter pylori Infection. London: Kluwer Academic; 1993:53-61.
83. Hirschowitz BI, Keeling D, Lewin M, et al. Pharmacological aspects of acid secretion. Dig Dis Sci. 1995;40(suppl):3S-23S.
84. Queiroz DM, Mendex EN, Rocha GA, et al. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol. 1993;28:858-864.
85. Moss SF, Legon S, Bishop AE, et al. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 1992;340:930-932.
86. Kaneko H, Nakada K, Mitsuma T, et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci. 1992;37:409-416.
87. Noach LA, Bosma NB, Jansen J, et al. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:425-429.
88. Karttunen R. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H pylori. Clin Exp Immunol. 1991;83:396-400.
89. Golodner EH, Soil AH, Walsh JH, Calam J. Release of gastrin from cultured canine G-cells by interferon-t and tumor necrosis factor-α. Gastroenterology. 1993; 104:A89. Abstract.
90. Beales I, Srinivasan S, Blaser MJ, et al. Effect of Helicobacter pylori constituents and inflammatory cytokines on gastrin release from isolated canine G cells. Gastroenterology. 1995;108:A779. Abstract.
91. Courillon-Mallet A, Launay JM, Roucayrol AM, et al. Helicobacter pylori infection:physiopathologic implication of N a-methyl histamine. Gastroenterology. 1995;108:959-966.
92. Hogan DL, Rapier RC, Dreilinger A, et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology. 1996;110:705-716.
93. Blaser MJ, Pérez-Pérez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111-2115.